COMPANY PROFILE -AstraZeneca
Business Sector :Biopharmaceutical and Pharmaceutical
Operating Geography :United Kingdom, Europe, Global
About AstraZeneca :
AstraZeneca is an Anglo-Swedish global pharmaceutical and biopharmaceutical company with headquarter in Cambridge, United Kingdom. The business is driven and led by science, technology and innovation, providing medicines used by millions of patients worldwide. The Swedish Astra AB and the British Zeneca Group were combined to form the company, which was established in 1999. It has been one of the largest pharmaceutical companies in the world since the merger and has made a number of business acquisitions, including Cambridge Antibody Technology in 2006, MedImmune in 2007, Spirogen in 2013, and Definiens in 2014. Three strategic locations host the majority of its research and development activities: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, United States. It has a market cap of $204.37 Billion as in July, 2022. The product portfolio on the group consists of medicines for curing diseases such as Cancer, Cardio vascular, Respiratory, Neuroscience, Oncology, Infection and Vaccines. AstraZeneca was awarded Company of the year 2020 by Scrip. In May 2022, AstraZeneca and RQ Biotechnology Ltd. (RQ Bio) entered into a licence agreement for a portfolio of early-stage monoclonal antibodies (mAbs) directed against COVID-19-causing SARS-CoV-2. According to the agreement, AstraZeneca has been granted the sole right to create, produce, and market mAbs that are effective against SARS-CoV-2.
The USP of AstraZeneca lies in it being under the Top 10 pharmaceutical companies in the world. AstraZeneca’s mission as per their website is to “turn ideas into life-changing medicines that improve patients’ lives and benefit society.”
AstraZeneca Revenue :
$ 37.42 Billion - FY ending 31st December 2021
$ 26.62 Billion - FY ending 31st December 2020
Competitive Analysis of AstraZeneca
The SWOT analysis for AstraZeneca is presented below:
Strengths | Weaknesses |
1. Ranked first in innovation index.
2. High percentage of R&D Expenditure amongst the industry leaders.
3. Strong financial performance.
| 1. Bad public relations image and other controversies
2. High failure rate for drug leads to high operational losses.
3. Problems of blood clots with their COVID-19 vaccine
|
Opportunities | Threats |
1. Vast growth opportunities in the emerging markets that can be future drivers for growth. | 1. Acquisition by financially bigger and wealthier companies.
2. Loss of revenue because of generics.
3. High drug development cost.
|
On purchase the AstraZeneca SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
Detailed SWOT Analysis of AstraZeneca
Strength
1. Ranked first in the Innovation Index: In 2018 AstraZeneca topped the Pharmaceutical Innovation Index released by IDEA pharma for the first time leading behind industry leaders such as Johnson&Johnson, Pfizer, Abbot, Novartis, Bayer, Sanofi, Glaxo Smith Kline and many others, AstraZeneca topped the ranking even though they were ranked on the 15th spot in 2017, this comes on the back of some key strategic decisions taken by the management at AstraZeneca that helped to pipeline the positive data and ideas and stem the company’s downward trend because of the loss of several exclusive products between the year 2011 and 2017. AstraZeneca was considerably behind in developing cancer immunotherapy drugs which the market leaders such as Merck, Roche and Bristol-Myers were also competing for but the successful test trials by AstraZeneca could give it a major advantage. The main reason that AstraZeneca topped the Pharmaceutical Innovation Index in 2018 from the 15th position was the launch of five new significant medicines in 2017 primarily across their therapy areas which are no mean feat for a company in the industry. Astrazeneca dropped two spots from the 6th rank in 2019, to the 8th rank in 2021. In 2020, Astrazeneca ranked 1st in the Invention Index due to their COVID-19 research and efforts.
2. High percentage of R&D expenditure amongst the industry leaders: In absolute spending on R&D AstraZeneca ranks at the 6th spot overall in the pharmaceutical industry in Financial Year 2017 despite being much smaller in size in terms of revenue than some of its competitors, it outperforms Bristol-Myers Squibb, Sanofi and GlaxoSmithKline all of which have a higher revenue than AstraZeneca, this comes on the back of a decline in revenue in 2017 by more than 2% than that in 2016, but the company showed positive results in the Q4 of FY 2017 where its revenue grew by 3% than that in Q4 of FY 2016. On an average the top ten Pharmaceutical companies by their market capitalization shelled out 17% of their revenues on R&D, whereas AstraZeneca proved to set the benchmark in this aspect as they spent just more than 25% of their revenues, this comes at a time when the total spending on R&D by the top 10 companies combined stood at $ 70 Billion in 2017 which has been stagnant for the past 5 to 6 years as the total spending of $ 70 Billion was spent in 2011 and 2012. In 2020, Astrazeneca’s R&D spending increased by 21% from their spending in 2019. The pharmacy company Roche invested the most overall but Astrazeneca saw the biggest jump in spending and it also invested the most as a percentage of their sales (24.8%).
The remaining section under "Strength" is available only in the 'Complete Report' on purchase.
Weakness
This section is available only in the 'Complete Report' on purchase.
Opportunity
This section is available only in the 'Complete Report' on purchase.
Threat
This section is available only in the 'Complete Report' on purchase.
The PESTLE/PESTEL analysis for AstraZeneca is presented below:
Political | Economical |
1. Uncertainty due to BREXIT.
2. Increased spending on healthcare by governments by providing healthcare programs (as Obama-care and Modi-care)
| 1. Steps taken by the Trump Government to lower drug prices.
2. Rising returns on the R&D investment in the pharmaceutical industry.
|
Social | Technological |
1. Aging population will lead to greater growth opportunities.
2. Significant growth in the number of patients suffering from diseases caused by urban lifestyle.
3. Rising income levels.
| 1. Investing in building innovation centre to promote quality manufacturing
2. Artificial Intelligence and tracking systems to aid in drug discovery and tackling counterfeits
|
Legal | Environmental |
1. Fluctuations in drug approval from the regulatory bodies.
2. Changes made in the corporate tax rate in the USA
3. Impact of GDPR on operation and development of drugs.
| 1. Leadership role taken by AstraZeneca to tackle the global climate change. |
On purchase the AstraZeneca SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
Detailed Pestle Analysis of AstraZeneca
Political
This section is available only in the 'Complete Report' on purchase.
Economic
This section is available only in the 'Complete Report' on purchase.
Social
1. Aging population will lead to higher growth opportunities: Several developed and developing countries have a high average age of the population which in the coming years will be beneficial for the pharmaceutical industry as more the age the higher the spending gets on healthcare. The revenue earned by the pharmaceutical industry worldwide in 2020 was $1228.45; significant revenue comes from only 4 geographical markets that are the USA, China, Europe and Japan with each contributing $370 Billion, $145 Billion, $188 Billion and $84 Billion respectively. The USA, China and Europe have an average age of population ranging between 36 to 39 years where it is expected that the average age of the population will reach 50 years by the year 2045 and this will give a major boost to the pharmaceutical industry just like Japan’s (average age-47) pharmaceutical market is huge considering the relatively small population of the country when compared to the USA, China and Europe.
The remaining section under "Social" is available only in the 'Complete Report' on purchase.
Technological
This section is available only in the 'Complete Report' on purchase.
Legal
This section is available only in the 'Complete Report' on purchase.
Environmental
This section is available only in the 'Complete Report' on purchase.
On purchase the AstraZeneca SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
You may also be interested in other analyses of AstraZeneca:
-
AstraZeneca Porter's Five Forces Analysis |
|
-
AstraZeneca VRIO Analysis |
|
-
AstraZeneca Value Chain Analysis |
|
-
AstraZeneca Covid-19 Impact Analysis |
|
-
-
AstraZeneca Segmentation, Targeting and Positioning (STP) Analysis |
|
-
AstraZeneca Ansoff Matrix Analysis |
|
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Company Overview Report
This report is shared in order to give you an idea of what the complete Company Overview Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Competitor Analysis Report
This report is shared in order to give you an idea of what the complete Competitor Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Porter's Five Forces Analysis Report
This report is shared in order to give you an idea of what the complete Porter's Five Forces Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
VRIO Analysis Report
This report is shared in order to give you an idea of what the complete VRIO Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Value Chain Analysis Report
This report is shared in order to give you an idea of what the complete Value Chain Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Regulatory Outlook Report
This report is shared in order to give you an idea of what the complete Regulatory Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Risk Analysis Report
This report is shared in order to give you an idea of what the complete Risk Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key Performance Indicators (KPI's) Report
This report is shared in order to give you an idea of what the complete Key Performance Indicators (KPI's) Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Environmental, Social, and Governance (ESG) Analysis Report
This report is shared in order to give you an idea of what the complete Environmental, Social, and Governance (ESG) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
M&A Analysis Report
This report is shared in order to give you an idea of what the complete M&A Report and Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Subsidiaries, Partnerships and Collaborations Report
This report is shared in order to give you an idea of what the complete Subsidiaries, Partnerships and Collaborations Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Stakeholder Analysis Report
This report is shared in order to give you an idea of what the complete Stakeholder Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Technology Landscape and Outlook Report
This report is shared in order to give you an idea of what the complete Technology Landscape and Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Covid-19 Impact Analysis Report
This report is shared in order to give you an idea of what the complete Covid-19 Impact Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key News and Events Report
This report is shared in order to give you an idea of what the complete Key News and Events Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
BCG Analysis Report
This report is shared in order to give you an idea of what the complete BCG Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Digital Marketing and Social Media Strategy Analysis Report
This report is shared in order to give you an idea of what the complete Digital Marketing and Social Media Strategy Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Segmentation, Targeting and Positioning (STP) Analysis Report
This report is shared in order to give you an idea of what the complete Segmentation, Targeting and Positioning (STP) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Ansoff Matrix Analysis Report
This report is shared in order to give you an idea of what the complete Ansoff Matrix Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Check Out Analysis of Other Relevant Companies
References used in AstraZeneca SWOT & PESTLE Analysis Report
1. Annual Report - https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2020/pdf/AstraZeneca_AR_2020.pdf
2. Meet the most innovative and inventive pharmaceutical companies of 2021 - https://fortune.com/2021/04/16/top-pharmaceutical-companies-innovation-invention-2021/
3. India Rejects AstraZeneca Patent Appeal - https://www.industryweek.com/innovation/intellectual-property/article/21958985/india-rejects-astrazeneca-patent-appeal
4. Why does it cost so much to develop new drugs? - https://www.proclinical.com/blogs/2020-9/why-does-it-cost-so-much-to-develop-new-drugs
The detailed complete set of references are available on request in the 'Complete report' on purchase.
How to Reference This Page?
You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.
AstraZeneca SWOT and PESTLE Analysis - SWOT & PESTLE.COM
SWOT & PESTLE.com (2025). AstraZeneca SWOT and PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/astrazeneca/ [Accessed 14 Feb, 2025].
In-text: (SWOT & PESTLE.com, 2025)
Copyrights and Disclaimer
AstraZeneca SWOT and PESTLE analysis has been conducted by Deepankar Pandey and reviewed by senior analysts from Barakaat Consulting.
Copyright of AstraZeneca SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.